A detailed history of Knott David M Jr transactions in Immunovant, Inc. stock. As of the latest transaction made, Knott David M Jr holds 91,500 shares of IMVT stock, worth $2.52 Million. This represents 0.96% of its overall portfolio holdings.

Number of Shares
91,500
Previous 85,300 7.27%
Holding current value
$2.52 Million
Previous $2.76 Million 12.34%
% of portfolio
0.96%
Previous 0.97%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$25.1 - $31.61 $155,620 - $195,982
6,200 Added 7.27%
91,500 $2.42 Million
Q1 2024

May 14, 2024

BUY
$30.27 - $43.79 $2.54 Million - $3.67 Million
83,815 Added 5644.11%
85,300 $2.76 Million
Q4 2023

Feb 13, 2024

BUY
$31.31 - $44.19 $46,495 - $65,622
1,485 New
1,485 $63,000

Others Institutions Holding IMVT

About Immunovant, Inc.


  • Ticker IMVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,077,000
  • Market Cap $3.55B
  • Description
  • Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...
More about IMVT
Track This Portfolio

Track Knott David M Jr Portfolio

Follow Knott David M Jr and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Knott David M Jr, based on Form 13F filings with the SEC.

News

Stay updated on Knott David M Jr with notifications on news.